2025 International Congress » Parkinson's Disease (Other)

“Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.

A. Sawal, A. Kumar, A. Singh, K. Alreja, S. Tomar, A. Tiwari (chandigarh, India)

A Multidimensional Biomarker Panel for The Early Detection of Parkinson’s Disease

N. Shebl, S. Mowafi, A. Arafa, M. Wahid, M. Salama (Mansoura, Egypt)

A Novel Therapeutic Targeting the tPA-NMDAr Interaction for Parkinson’s Disease

M. Blanc, E. Su, D. Torrente, B. Zhang, D. Vivien, F. Lesept, N. Deletage (Lyon & Caen, France)

A Scoping Review of Psychological Interventions across domains to improve Quality of Life in Persons with Parkinson’s Disease

S. Desai, D. Desai (Anand, India)

A scoping review of safer mobility behaviour for falls prevention: Implications for people with Parkinson’s disease.

D. Cheung, J. Wesson, S. Paul, L. Mackenzie, L. Goh, C. Canning, L. Almeida, M. Enright, N. Allen (Camperdown, Australia)

A Systematic Review on the Reliability of Data-Driven Parkinson’s Disease Subtypes

D. Teixeira-Dos-Santos, R. Ravazio, C. Mattjie, A. De-Oliveira-Franco, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, MA. de Bastiani, MA. Machado Schlindwein, L. Angi Souza, T. Hugentobler Schlickmann, S. Duarte Pinto, A. Bieger, R. C. Barros, E. R. Zimmer, AF. Schumacher Schuh (Porto Alegre, Brazil)

Access to Allied Health Services by People Living with Parkinson’s Disease: A Qualitative Study

C. Wong, S. Dennis, N. Allen, S. Paul (Camperdown, Australia)

Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach

L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret (London, United Kingdom)

Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings

T. Yinesu, Z. Bayu (Addis Ababa, Ethiopia)

AI-Driven Prediction Models for Advanced Parkinson’s Disease: A Data-Driven Approach Using PPMI and CDEPA Criteria

I. Gabilondo, A. Saenz, S. Seijo, A. Ochoa, U. Zalabarria, I. Cuenca, B. Tijero, T. Fernandez, M. Ruiz, M. Acera, J. Gomez, R. Del Pino (Barakaldo, Spain)

AI-Driven Wearable Sensor Monitoring for Improved Assessment of Advanced Treatment Readiness in Parkinson’s Disease – A pilot study

N. Karottki, M. Sander, T. Hørmann Thomsen, B. Biering-Sørensen (Glostrup, Denmark)

Aquatic Interval Training in Individuals with Parkinson’s Disease: Can It Improve Gait?

T. Christinelli, G. Leveck, L. Paladini, S. Souza, V. Israel (Curitiba, Brazil)

Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics

L. Abu Zohair, H. Zantout, M. Vallejo, M. Uddin (Edinburgh, United Kingdom)

Assessing Physiotherapy’s Role in Parkinson’s Disease Functionality in India: A Case Report

K. Thangavelu (Gurugram, India)

Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)

Automating the assessment of motor symptoms of Parkinson’s: exploring the scope of assessment possible in a video-based approach.

A. Podlewska, R. Singh, M. Squires, B. Bridges (London, United Kingdom)

Barriers to Healthcare Utilization and Adherence to Medications among People Living with Parkinson’s Disease in Senegal

M. Njohjam, M. Fall, F. Niakam, J. Kahwagi, A. Diop, M. N, A. Diop (Dakar, Senegal)

Barriers To Physical Exercise Adherence In Individuals With Parkinson’s Disease: A Cross-Sectional Study

S. Souza, G. Leveck, T. Christinelli, L. Paladini, V. Israel (Curitiba, Brazil)

Beyond Medication: The Potential of Diet in Parkinson’s Management

G. Hitawala, L. Shulman (Baltimore, USA)

Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)

Caregiver Burden after DBS at GPI or STN for Parkinson’s Disease

A. Kamath, H. Branstetter, J. Summers, T. Hassell, S. Bick, N. Banerjee, K. Dhima (Nashville, USA)

Cerebrospinal fluid DOPA decarboxylase levels as a marker of disease severity in Parkinson’s Disease

K. Groenewald, L. van Hillegondsberg, T. Eisenstein, J. Klein, M. Hu (Oxford, United Kingdom)

Clinical Characteristics and Biomarkers in Parkinson’s Disease Patients with Body-first versus Brain-first Subtypes in Parkinson’s Disease

S. Li, Y. Tang, J. Wang (Shanghai, China)

Clinical Efficacy, Cost Effectiveness, and Caregiver Satisfaction of the Application of Parkinson’s KinetiGraph (PKG) in Clinical Practice versus Standard Care – a 12-month Longitudinal Analysis Part of the EmPARK-PKG Project

V. Metta, M. Qamar, H. Benamer, T. Loney, G. Goyal, R. Dhamija, P. Kukle, R. Borgohain, R. Mridula, H. Hussain, A. Nalarakettil, R. Chaudhuri (London, United Kingdom)

Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence

R. Dolhun, D. Kumbroch, K. Klapper, K. Wu, L. Holding, K. Callahan (New York, USA)

Clinicians’ Views on the Use of a Patient Decision Aid for DBS in Parkinson’s Disease

H. King, J. Blumenthal-Barby, B. Levi, S. de Jesus, L. Cabrera (University Park, USA)

Contribution of β-band functional connectivity to the α-synuclein propagation in early-stage Parkinson’s Disease: insights from the analysis of brain network properties

M. Conti, A. Guerra, V. Ferrari, V. D'Onofrio, G. Sancesario, M. Pierantozzi, NB. Mercuri, A. Antonini, T. Schirinzi, A. Stefani (Rome, Italy)

Depression and Social Engagement in Community-Dwelling Older Adults with Parkinsonism

M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

Designing a Cultural Dance Program for People with Parkinson’s Disease

J. Takata, K. Tolentino, R. Shuman, M. Look, K. Thai, E. Krening, F. Gao, L. Jaffe, T. Seto, M. Bruno (Honolulu, USA)

Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group

R. Mehanna, C. Marras, J. Fleisher, B. Post, K. Kumar, A. Noyce, R. Alcalay, H. Morris, T. Hatano, M. Salari, K. Smilowska, Y. Wu, B. Zhang, E. Tan, R. Savica (Houston, USA)

Digital Health Interventions for Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

RW. Liu, SR. Zhang, YF. Chen, HF. Shang (Chengdu, China)

EEG connectivity in Parkinson disease: a comparative analysis of sporadic and genetic forms in ON/OFF therapy.

M. Treddenti, V. Yahya, S. Marceglia, V. D'Onofrio, A. Guerra, T. Bocci, A. Priori (Milan, Italy)

Effects of Low-Intensity Exercise on Motor and Non-Motor Symptoms in a 6-OHDA-Induced Rat Model of Parkinson’s Disease

SP. Tsao, YW. Chen, HY. Huang (Taipei, Taiwan)

Efficacy of adhering to a Ketogenic Diet in Parkinson’s Disease: a Systematic Review and Meta-Analysis

G. Guindani Maia, V. Ritt Xavier, V. Serafim, M. Neto, L. Nardi Motta, V. Müller, I. Alicia Fink, AC. Sgarioni Viapiana, MF. Peruci Felippe, L. Bedatti Koehler, C. Rieder (Porto Alegre, Brazil)

End-of-life care management in Parkinson’s disease: a national survey of caregivers’s own experiences and perceptions

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

Engage- Qatar PD: The development of an online self-management intervention to promote engagement in physical activity for people with PD in Qatar

H. Khalil, R. Hammad, M. Rawash, S. Pedersen, L. Morris, M. Choudhury, L. Quinn, A. Oun (Doha, Qatar)

Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring

F. Chmell, P. Lee, M. Sander (München, Germany)

Enhancing Safety and Quality of Care for Parkinson’s Disease Patients Hospitalized at a Large Academic Medical Center

C. Kim, C. Malatt, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)

Enhancing Sleep in Parkinson’s Disease: A Retrospective Study on Group CBT-I

N. Hellmers, A. Weiss, D. Zhang, P. Glovinsky, D. Barone, A. Yoo, H. Ooi, H. Sarva (New York, USA)

Freezing of Gait Detection and Warning System for Parkinson’s Patients

D. Kusbeci, T. Ozkarslioglu, N. Durmaz Celik, Z. Saatci (Izmir, Turkey)

Frequency and outcome of PEG tube implantations in hospitalized Parkinson’s disease patients

R. Burke, T. Mehta, H. Kamo, M. Okun, C. Hess, M. Remz (Gainesville, USA)

Gait Analysis in Parkinson’s Disease with Mixed Reality

M. Wójcik-Pędziwiatr, D. Hemmerling, J. Stępień, M. Yufan, M. Kaczmarska, W. Szecówka, A. Srinivasa, M. Rudzińska-Bar (Cracow, Poland)

Gait Assessment for Parkinson’s Disease Patients Utilizing a Pressure Sensor Insole System

G. Karamanis, I. Boura, V. Skaramagkas, C. Chatzaki, I. Kyprakis, D. Fotiadis, M. Tsiknakis, C. Spanaki, Z. Kefalopoulou (Rion, Patras, Greece)

Gut Dysbiosis Alters Host Metabolism but Does Not Independently Induce Parkinson’s Disease Pathology

HY. Huang, TH. Yeh, SP. Tsao (Taipei, Taiwan)

Gym Strength Training for People with Early Onset Parkinson’s disease

M. Morris, C. Thwaites, D. Harris, M. Callisaya, R. Mouer, R. Blaze (Bundoora, Australia)

Hospitalization Safety in Parkinson’s Disease (PD): Baseline Outcomes Tracked over 1 Year and a Multi-disciplinary Program to Improve Care

A. Carpentier, H. Martin, M. Musalo, I. Malaty (Montreal, Canada)

Hyperbaric Oxygen Therapy for Parkinson’s disease via modulation of gut microbiota

V. Vedam-Mai, J. Long, N. Nair, D. Fuller, K. Deegan, S. Rana, G. Iglesias, I. Gonzalez, U. Dissanayake, V. Mai (Gainesville, USA)

Hypomimia in triggered smiling in patients with Parkinson’s disease

S. Obika, C. Trompeta, R. Rodríguez-Rojas, M. Matarazzo, A. Ruiz-Yanzi,, P. Guida, T. Jiménez, D. Urso, B. Fernández-Rodríguez, J. Obeso, C. Gasca-Salas (Madrid, Spain)

Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)

Impact of Cognition on Social Engagement in Community-based Older Adults with Parkinsonism

M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

Impact of Stigma on Patients Diagnosed with Parkinson’s Disease in Buenos Aires (Argentina) : A Descriptive Study of Psychological, Occupational, and Social Dimensions

JS. Bestoso, R. Sanjinez, J. Ayerbe, C. Stefani, L. Ciancaglini, V. Müller, D J. Bauso (Buenos Aires, Argentina)

Improving Guitar Strumming Mechanics in Parkinson’s Disease: A Case Series Using a Forearm Stabilization Device

J. Lenger, S. Matsushita, T. Lesiuk, M. Kerulis, N. Punjabi (Miami, USA)

Improving Vocal Volume and Quality of Life for People with Parkinson’s Disease (PD) utilizing EMST and SPEAK OUT!® in the In-Patient Multimodal Intensive Neurorehabilitation And Care Setting.

P. Fischetti, J. Yu, M. Mccrossin, L. Rubin (Glen Cove, USA)

Incidence and Determinants of Nodule formation in continuous subcutaneous Foslevodopa/Foscarbidopa Infusion therapy.

S. Bray, D. Tsui, M. Georgiades, X. Chen, D. Galea, H. Morales Briceno, V. Fung (Westmead, Australia)

Initial Evaluation of a Body-worn Bilateral Sensory Electrical Stimulation Cueing System in Reducing Freezing of Gait (FoG) in a Patient in the OFF and ON States

A. Pérez-Soriano, F. Fondevilla, N. Caballol, K. Byrne, G. ólaighin, à. Bayés (Barcelona, Spain)

Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)

Investigation of cortex – basal ganglia pathways with cortical stimulation and subthalamic evoked responses in patients with Parkinson’s disease

J-C. Beyer, A. Cavallo, R M. Köhler, J. Vanhoecke, G-H. Schneider, A A. Kühn, W-J. Neumann (Berlin, Germany)

IPX203 (ER CD-LD) super-responders: Description of a patient subpopulation reaping extra benefits in dose-response when converting from IR CD-LD

S. Allard, G. Banisadr, S. Fisher, P. Lewitt (Bridgewater, USA)

Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease

S. Kolipaka, H. Kong, P. Izbicki (Boca Raton, USA)

Key components for safer mobility behaviour assessment and intervention for people with Parkinson’s disease: A modified Delphi study

D. Cheung, S. Paul, L. Mackenzie, J. Wesson, N. Allen (Camperdown, Australia)

Lewy Pathology in the Peripheral Nervous System of SNCA Duplication

G. Beck, M. Yamadera, A. Tarutani, Y. Yonenobu, M. Hasegawa, S. Murayama, H. Mochizuki (Suita, Japan)

Likelihood to consent within the PREDICT-PD cohort: Identifying potential barriers or promoters of involvement in longitudinal Parkinson’s research

S. Meyer, R. Benabderrazik, H. Chohan, A. Shahid, R. Lathey, L. Smith, C. Simonet, L. Pérez-Carbonell, E. de Pablo-Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

Long-Term Benefits of Weekly Group Physiotherapy in Slowing Parkinson’s Progression:A 12-Month Non-Randomized Controlled Trial

E. Tardelli, M. Piemonte, B. Rosa, P. Igarashi, C. Dias (São Paulo, Brazil)

Longitudinal Analysis of BRAIN test in isolated REM sleep behaviour disorder with and without hyposmia.

H. Chohan, T. Tocino, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

Movement-Disorders Focused Clinical Neuroscience Training for Psychiatry Residents: A Competency-Based Medical Education Model

A. Seritan (San Francisco, USA)

Noise assessment acoustic measures of sustained vowel in patients with Parkinson’s disease

I. Khasanov, D. Khasanova (Kazan, Russian Federation)

Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention

J. Acquaviva, S. Maguire, Y. Xu, E. Feinstein (Newark, USA)

Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies

N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

Nutritional Parameter Changes in Parkinson’s Disease Patients Receiving Continuous Subcutaneous Infusion of Foslevodopa-Foscarbidopa

M. Barichella, MC. Macchione, G. Lazzeri, E. Cereda, I. Ioannis, G. Pezzoli (Milano, Italy)

Online Learning Preferences of Healthcare Providers Caring for People with Parkinson’s Disease

A. Smiley, I. Blackwood, L. Hoffman, R. Miller, K. Fitzgerald, C. Gadala-Maria, E. Pollard, A. Paul (Miami, USA)

Optimizing deep brain stimulation programming settings for patients with stimulation-induced dyskinesias in Parkinson’s disease

S. Kaul, J. Deng, D. Fletcher, L. Colantonio, A. Memon, MC. Moreno-Escobar, A. Murray, G. Adams, J. Frey (Morgantown, USA)

Paeoniflorin Combined with Neural Stem Cell Transplantation for Parkinson’s Disease: Synergistic Effects of Cell Therapy and Inflammation Regulation

SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

Parkinson’s Disease Dogs to assist Gait Impairment: A Pilot study of Patient Experience and Outcomes

A. Gallagher, C. O'Keeffe, J. Inocentes, J. Liegey, J. Dowler, C. Fearon, T. Lynch (Dublin, Ireland)

Parkinson’s Disease Health Policy in 7 African Countries: Results of a Transforming Parkinson’s Care in Africa (TraPCAf) Review

R. Morton, A. Rogers, H. Francis, M. Cham, J. Lumsdon, C. Dotchin, E. Hamid, A. Akpalu, S. Gugssa, B. Mushengezi, O. Ojo, N. Okubadejo, D. Sokhi, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

Parkinson’s Exercise Guidelines: From Outdated to Updated

M. Rafferty, L. Hoffman, L. Krasucki, D. Corcos (Chicago, USA)

Parkinson’s Progression Markers Initiative (PPMI): A Biomarker Engine for Therapeutic Development for PD and Related Synucleinopathies

B. Mcmahon, A. Videnovic, A. Siderowf, B. Mollenhauer, C. Tanner, C. Coffey, C. Stanley, D. Weintraub, D. Galasko, E. Flagg, E. Brown, K. Merchant, K. Kieburtz, K. Poston, K. Marek, K. Fabrizio, L. Chahine, M. Kuhl, M. Frasier, R. Dobkin, R. Alcalay, S. Chowdury, T. Simuni, T. Foroud, T. Sherer, T. Tropea (Boston, USA)

PARKinSOUND 2.0: The Impact of Orchestra Participation on Patients with Parkinson’s Disease

S. Lopes, A. Ferreira, S. Gomes, C. Morgado, L. Costa, A. Goios, J. Ferreira, M. Rodrigues (Braga, Portugal)

Patient engagement in Parkinson’s research: Exploring stakeholder perspectives

J. Bek, N. Simonian, C. Rattan, A. Asis (Dublin, Ireland)

PHIT-Brain Study Protocol: Adaptation and Evaluation of a Multifaceted Brain Health Intervention for Patients with Parkinson’s Disease and Mild Cognitive Impairment (PD-MCI)

G. Roth, D. Gonzalez (Chicago, USA)

Promising Remote Markers of Motor Progression in Isolated REM Sleep Behaviour Disorder

M. Patyjewicz, A. Zirra, B. Kansu, H. Chohan, L. Pérez-Carbonell, A. Noyce, C. Simonet (London, United Kingdom)

Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

T. Lata (Mumbai, India)

Protective effects of Hesperidin loaded polymeric nanoparticles on the progression of MPTP Induced Parkinson’s disease via targeting GPR43/NLRP3 signaling pathway: in vitro and in vivo studies

M. Singh (Prayagraj, India)

Qualitative research in advanced Parkinson’s disease: Exploring salient symptoms and suitability of the MDS-NMS from the patient, caregiver, and clinician perspective

N. Williamson, A. Lydon, S. Wallace, E. Taylor, M. Chaudry, H. Bradley, R. Williams-Hall, P. Boccon-Gibod, K. Raphael, E. Stevens, P. Odin, A. Antonini, M. Biagioni (Bollington, United Kingdom)

Quantitative assessment of micrographia and bradykinesia in Parkinson’s disease

S. Obika, J. Ortega, M. Escribano, A. Ruiz-Yanzi, C. Del Toro, E. Natera-Villalba, C. Gasca-Salas, M. Matarazzo, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Madrid, Spain)

Relationships Between Preferred Walking Speed and Accelerations at the Head and Trunk in Individuals with Parkinson’s Disease (PD) and Healthy Elderly

P. Prupetkaew, A. Grunsfeld, S. Morrison, D. Russell (Norfolk, USA)

Repeated Scanning Ultrasound in an Alpha-synuclein Preformed Fibril model

V. Purrer, K. Roffey, G. Richter-Stretton, J. Song, G. Leinenga, L. Chen, E. Albornoz Balmaceda, J. Götz (St Lucia, Australia)

Retro walking: A Potential Indicator of Physical Frailty in Parkinson’s Disease.

M. van Emde-Boas, C. Stonsaovapak, N. Bohnen, C. Pongmala (Ann Arbor, USA)

Sex differences in regional densities of Lewy body pathology

C. Tremblay, S. Chiu, G. Serrano, C. Adler, H. Shill, E. Driver-Dunckley, S. Mehta, C. Belden, D. Shprecher, Y. Zeighami, M. Dadar, A. Atri, T. Beach, P. Choudhury (Montreal, Canada)

Spatiotemporal Gait Norms in Moderate-to-Advanced Parkinson’s Disease

K. Miller, R. Tripathi, S. Solano, S. Factor, J. Mckay, C. Esper (Atlanta, USA)

Stretegy of self-care in patient with Parkison disease: a metasynthesis

M. Petralito, C. Tedesco, I. Milani, G. Pucciarelli, R. Caruso (Roma, Italy)

Studying the relationship between interoceptive awareness, caregiver burden, and disease perception in Parkinson’s Disease

F. Velasco-Delgado, A. Hernandez-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, G. Martin-Mafud (Mexico City, Mexico)

Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)

Targeted Brain Delivery of Rifampicin via PEG-PLA Nanoparticles: A Promising Therapeutic Strategy for Neuroprotection and Disease Modification in Parkinsonian Mouse Models

JH. Su, EX. Tao (Shenzhen, China)

The Effect of Melatonin on Sleep Quality and Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

A. Zrineh, R. Akwan, MM. Elsharkawy, B. Douden, W. Sleibi, M. Eldesouki (Al-Quds, State of Palestine)

The Effectiveness of Drug-Disease Best Practice Advisory Alerts for Preventing the Administration of Contraindicated Medications in Patients with Parkinsonism

A. Kundrick, M. Fedorova, B. Sokola, B. Walter (Cleveland, USA)

The MJFF PRKN/PINK1 Project

E-J. Vollstedt, A. Balck, AN. Basak, M. Brand, N. Brüggemann, J-C. Corvol, S. Ertan, M. Funayama, M. Gagliardi, N. Hattori, C-H. Lin, K. Lohmann, P. Mir, D. Narendra, G. Saranza, L. Stefanis, A-H. Tan, EM. Valente, S. Padmanabhan, K. Brockmann, C. Klein (Luebeck, Germany)

The nurse-led future of Parkinson care: A thematic analysis of healthcare professionals’ experiences with nurse-led care implementation.

T. Peerbolte, D. Speelberg, B. Maas, I. van Noorden, L. Hoogendoorn, S. Darweesh, B. Bloem, S. vd Berg, N. de Vries, M. Meinders (Nijmegen, Netherlands)

The Potential Long-Term Economic Impact of Continuous Monitoring in Parkinson’s Disease

S. Kontaxis, F. Kanellos, G. Rigas, N. Kostikis, S. Konitsiotis (Ioannina, Greece)

The Relationship among Depression, Self-Esteem, and Sense of Coherence in Patients with Parkinson’s Disease

Y. Ando, T. Yamawaki, Y. Ueki, S. Okuda, N. Tsuchikawa, K. Keiji, T. Kobayashi (HIroshima, Japan)

The Role of Research and Genetics Educational Events in Parkinson’s Research: Overcoming Barriers in the Hispanic Community

A. Coral-Zambrano, M. Rodriguez Violante, J. Orozco Velez, M. Inca Martinez, I. Mata, P. Hodges, R. de León (Miami, USA)

Therapeutic Efficacy of Human Dental Pulp Stem Cells-Derived Exosome-Encased Phloroglucinol In MPTP-Induced Chronic Parkinsonian Rat model: Potential for Disease Modification

I. Datta, K. Mondal, R. Ghanty, G. Wagmare, A. Mahadevan, R. Santhoshkumar, N. Bn (Bengaluru, India)

Theta burst transcranial ultrasound stimulation of internal globus pallidus and motor cortex in Parkinson’s disease

YY. Lin, N. Raies, T. Grippe, A. Bhattacharya, C. Sarica, G. Darmani, R. Chen (Taoyuan City, Taiwan)

Transcranial direct current stimulation combined with motor training for motor symptoms in Parkinson’s disease: a systematic review and meta-analysis

J. Jun, R. Kim (Seoul, Republic of Korea)

Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts

N. Howe, P. Walker, C. Mutepfa, S. Pretorius, A. Ponzo, C. Carroll, J. Suklan (Plymouth, United Kingdom)

Traumatic DBS Implant exposure following head injury and its management – a case report.

A. Uppar (BANGALORE, India)

Tumeric and Curcumin Improve Motor Function and Reduce Catalepsy in a Rotenone -Induced Parkinson’s Disease Model

L. Darbinyan, L. Hambardzumyan, K. Simonyan, V. Sarkisian, L. Manukyan (Yerevan, Armenia)

Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt

N. Shebl, S. Mondal, F. Waheed, A. Farag, N. Abonar, M. Abdelhady, S. Asran, M. Salama, M. Rizig (Cairo, Egypt)

Virtual Reality Boxing Program for Individuals with Parkinson’s Disease; A Quality Improvement Project.

F. Jamal, D. Padilla (Houston, USA)